stocks logo

SLS Financial Analysis

Sellas Life Sciences Group Inc
$
1.040
0.000(0.000%)

SLS Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-100.00%
1,000K
-82.46%
0.00
-100.00%
0.00
1.90M
5.70M
1.90M
0.00
0.00
0.00
Revenue from Goods & Services
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-100.00%
1,000K
-82.46%
0.00
-100.00%
0.00
1.90M
5.70M
1.90M
0.00
0.00
0.00
Cost of Goods Sold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-100.00%
100.00K
0.00%
0.00
0.00
100.00K
100.00K
0.00
0.00
0.00
0.00
Gross Profit
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-100.00%
900.00K
-83.93%
0.00
-100.00%
0.00
1.80M
5.60M
1.90M
0.00
0.00
0.00
Selling General & Administrative Expenses
6.92M
-15.40%
7.33M
-21.71%
7.62M
-15.79%
9.65M
-14.50%
8.18M
-13.43%
9.36M
31.00%
9.05M
4.95%
11.28M
47.75%
9.45M
59.59%
7.15M
2.42%
8.62M
37.90%
7.64M
-2.68%
5.92M
-2.31%
6.98M
55.32%
6.25M
46.54%
7.85M
93.04%
6.06M
30.41%
4.49M
7.36%
4.27M
6.17%
4.06M
Research & Development Expense
4.44M
-12.95%
4.36M
-24.96%
5.19M
-12.44%
5.11M
-28.76%
5.10M
-12.81%
5.81M
35.75%
5.92M
7.13%
7.17M
55.58%
5.85M
72.30%
4.28M
-5.70%
5.53M
59.98%
4.61M
7.63%
3.39M
22.45%
4.54M
91.85%
3.46M
51.58%
4.28M
129.83%
2.77M
23.37%
2.37M
31.57%
2.28M
65.10%
1.86M
Operating Profit
-6.92M
-15.40%
-7.33M
-21.71%
-7.62M
-15.79%
-9.65M
-14.50%
-8.18M
-13.43%
-9.36M
31.00%
-9.05M
4.95%
-11.28M
67.50%
-9.45M
59.59%
-7.15M
2.42%
-8.62M
93.64%
-6.74M
200.00%
-5.92M
42.32%
-6.98M
55.32%
-4.45M
4.36%
-2.25M
-44.76%
-4.16M
-10.48%
-4.49M
7.36%
-4.27M
6.17%
-4.06M
Financing Income- Net
181.00K
341.46%
221.00K
135.11%
151.00K
-27.40%
79.00K
-56.59%
41.00K
-74.05%
94.00K
-15.32%
208.00K
352.17%
182.00K
9000.00%
158.00K
111.00K
5450.00%
46.00K
2200.00%
2.00K
0.00%
0.00
-100.00%
2.00K
2.00K
100.00%
2.00K
-91.67%
1,000
-96.30%
0.00
-100.00%
1,000
-94.44%
24.00K
Interest Expense
-181.00K
341.46%
-221.00K
135.11%
-151.00K
-27.40%
-79.00K
-56.59%
-41.00K
-74.05%
-94.00K
-15.32%
-208.00K
352.17%
-182.00K
9000.00%
-158.00K
-111.00K
5450.00%
-46.00K
2200.00%
-2.00K
-0.00%
0.00
-100.00%
-2.00K
-2.00K
100.00%
-2.00K
-91.67%
-1,000
-96.30%
0.00
-100.00%
-1,000
-94.44%
-24.00K
Other Non-Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Income before Taxes
-6.74M
-17.20%
-7.11M
-23.30%
-7.47M
-15.50%
-9.57M
-13.80%
-8.14M
-10.80%
-9.27M
31.97%
-8.84M
5.06%
-11.10M
-33.73%
-9.12M
33.45%
-7.02M
-0.89%
-8.41M
82.40%
-16.74M
596.80%
-6.84M
83.10%
-7.09M
58.39%
-4.61M
4.25%
-2.40M
-42.00%
-3.73M
-50.23%
-4.47M
6.45%
-4.43M
41.19%
-4.14M
Income Taxes
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-237.00K
1294.12%
0.00
0.00
0.00
-17.00K
-79.01%
0.00
0.00
0.00
Net Income after Tax
-6.74M
-17.20%
-7.11M
-23.30%
-7.47M
-15.50%
-9.57M
-13.80%
-8.14M
-10.80%
-9.27M
31.97%
-8.84M
5.06%
-11.10M
-33.73%
-9.12M
38.24%
-7.02M
-0.89%
-8.41M
82.40%
-16.74M
596.80%
-6.60M
77.56%
-7.09M
58.39%
-4.61M
4.25%
-2.40M
-42.00%
-3.72M
-49.91%
-4.47M
6.45%
-4.43M
41.19%
-4.14M
Income Available to Common Shares
-6.74M
-17.20%
-7.11M
-23.30%
-7.47M
-15.50%
-9.57M
-13.80%
-8.14M
-10.80%
-9.27M
31.97%
-8.84M
5.06%
-11.10M
-33.73%
-9.12M
38.24%
-7.02M
-0.89%
-8.41M
82.40%
-16.74M
596.80%
-6.60M
77.56%
-7.09M
58.39%
-4.61M
4.25%
-2.40M
-43.07%
-3.72M
-49.91%
-4.47M
-61.00%
-4.43M
8.30%
-4.22M
EPS - Basic
-0.09
-65.38%
-0.10
-69.70%
-0.13
-58.06%
-0.21
-55.32%
-0.26
-40.91%
-0.33
-2.94%
-0.31
-24.39%
-0.47
-55.24%
-0.44
4.76%
-0.34
-24.44%
-0.41
36.67%
-1.05
556.25%
-0.42
16.67%
-0.45
-15.09%
-0.30
-54.55%
-0.16
-75.76%
-0.36
-76.62%
-0.53
-99.60%
-0.66
-89.57%
-0.66
EPS - Diluted
-0.09
-65.38%
-0.10
-69.70%
-0.13
-58.06%
-0.21
-55.32%
-0.26
-40.91%
-0.33
-2.94%
-0.31
-24.39%
-0.47
-55.24%
-0.44
4.76%
-0.34
-24.44%
-0.41
36.67%
-1.05
556.25%
-0.42
16.67%
-0.45
-15.09%
-0.30
-54.55%
-0.16
-75.76%
-0.36
-76.62%
-0.53
-99.60%
-0.66
-89.57%
-0.66
EBIT
-6.92M
-15.40%
-7.33M
-21.71%
-7.62M
-15.79%
-9.65M
-14.50%
-8.18M
-13.43%
-9.36M
31.00%
-9.05M
4.95%
-11.28M
67.50%
-9.45M
59.59%
-7.15M
2.42%
-8.62M
93.64%
-6.74M
200.00%
-5.92M
42.32%
-6.98M
55.32%
-4.45M
4.36%
-2.25M
-44.76%
-4.16M
-10.48%
-4.49M
7.36%
-4.27M
6.17%
-4.06M
EBITDA
-6.92M
-15.40%
-7.33M
-21.71%
-7.62M
-15.79%
-9.65M
-14.50%
-8.18M
-13.43%
-9.36M
31.00%
-9.05M
4.95%
-11.28M
67.50%
-9.45M
59.59%
-7.15M
2.42%
-8.62M
93.64%
-6.74M
200.00%
-5.92M
42.32%
-6.98M
55.32%
-4.45M
4.36%
-2.25M
-44.76%
-4.16M
-10.48%
-4.49M
7.36%
-4.27M
6.17%
-4.06M
Depreciation Depletion & Amortization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

SLS FAQs

What is SLS's PE Ratio in 2025/4/4?

SLS's PE ratio in April 4, 2025 is -2.06. This indicates the price investors are willing to pay for $1 of earnings.

What is SLS's PS Ratio in 2025/4/4?

What is SLS's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is SLS earnings result positive or negative?How should I trade on SLS earnings?